Delineation of the motilin domain involved in desensitization and internalization of the motilin receptor by using full and partial antagonists

Biochemical Pharmacology

Volumn 73, Issue 1, 2007, Pages 115-124

  Mitselos, Anna ^a   Depoortere, Inge ^a   Peeters, Theo L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Desensitization; Internalization; Motilin agonist; Motilin antagonist; Motilin receptor; Phosphorylation

Indexed keywords

AEQUORIN; ENHANCED GREEN FLUORESCENT PROTEIN; GM 109; HORMONE DERIVATIVE; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; MA 2029; MOTILIN; MOTILIN RECEPTOR; MOTILIN[1-14]; MOTILIN[1-22]; N ETHYL (4 FLUORO N METHYLPHENYLALANYL N METHYLVALINE) 3 TERT BUTYLTYROSINAMIDE; PHENYLALANINE CYCLO[LYSYLTYROSYL (3 TERT BUTYL)ALANINE]TRIFLUOROACETATE; PHENYLALANINE[1-14]; PHENYLALANINE[1-22];

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; DESENSITIZATION; FLUORESCENCE; HYPOTHESIS; IMMUNOPRECIPITATION; INTERNALIZATION; LUMINESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOCYTOSIS; GREEN FLUORESCENT PROTEINS; LIGANDS; MOTILIN; PHOSPHORYLATION; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE;

EID: 33845196470     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.09.011     Document Type: Article

References (48)

1. Itoh Z., Honda R., Hiwatashi K., Takeuchi S., Aizawa I., Takayanagi R., et al. Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol Suppl 39 (1976) 93-110
2. Vantrappen G., Janssens J., Peeters T.L., Bloom S.R., Christofides N.D., and Hellemans J. Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci 24 (1979) 497-500
3. Itoh Z., Nakaya M., Suzuki T., Arai H., and Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 247 (1984) G688-G694
4. Peeters T., Matthijs G., Depoortere I., Cachet T., Hoogmartens J., and Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol 257 (1989) G470-G474
5. Peeters T.L., Muls E., Janssens J., Urbain J.L., Bex M., Van Cutsem E., et al. Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Gastroenterology 102 (1992) 97-101
6. Peeters T.L. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105 (1993) 1886-1899
7. Janssens J., Peeters T.L., Vantrappen G., Tack J., Urbain J.L., De Roo M., et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 322 (1990) 1028-1031
8. Talley N.J., Verlinden M., Snape W., Beker J.A., Ducrotte P., Dettmer A., et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 14 (2000) 1653-1661
9. Talley N.J., Verlinden M., Geenen D.J., Hogan R.B., Riff D., McCallum R.W., et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 49 (2001) 395-401
10. Tack J., and Peeters T. What comes after macrolides and other motilin stimulants?. Gut 49 (2001) 317-318
11. Peeters T.L. New motilin agonists: a long and winding road. Neurogastroenterol Motil 18 (2006) 1-5
12. Thielemans L., Depoortere I., Perret J., Robberecht P., Liu Y., Thijs T., et al. Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther 313 (2005) 1397-1405
13. Lamian V., Rich A., Ma Z., Li J., Seethala R., Gordon D., et al. Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis. Mol Pharmacol 69 (2006) 109-118
14. 3]porcine motilin fragments. Peptides 13 (1992) 565-569
15. Miller P., Gagnon D., Dickner M., Aubin P., St-Pierre S., and Poitras P. Structure-function studies of motilin analogues. Peptides 16 (1995) 11-18
16. Peeters T.L., Macielag M.J., Depoortere I., Konteatis Z.D., Florance J.R., Lessor R.A., et al. D-amino acid and alanine scans of the bioactive portion of porcine motilin. Peptides 13 (1992) 1103-1107
17. Khan N., Graslund A., Ehrenberg A., and Shriver J. Sequence-specific 1H NMR assignments and secondary structure of porcine motilin. Biochemistry 29 (1990) 5743-5751
18. Thielemans L., Perret J., Depoortere I., Robberecht P., and Peeters T.L. The C-terminal domain of motilin is required for complete homologous desensitization and endocytosis. Gastroenterology 124 (2003) A-119 [Abstract]
19. Peeters T.L., Depoortere I., Macielag M.J., Dharanipragada R., Marvin M.S., Florance J.R., et al. The motilin antagonist ANQ-11125 blocks motilide-induced contractions in vitro in the rabbit. Biochem Biophys Res Commun 198 (1994) 411-416
20. 3]porcine motilin. Eur J Pharmacol 286 (1995) 241-247
21. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
22. Thielemans L., Depoortere I., Vanden Broeck J., and Peeters T.L. The motilin pharmacophore in CHO cells expressing the human motilin receptor. Biochem Biophys Res Commun 293 (2002) 1223-1227
23. Takanashi H., Yogo K., Ozaki K., Ikuta M., Akima M., Koga H., et al. GM-109: a novel, selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. J Pharmacol Exp Ther 273 (1995) 624-628
24. January B., Seibold A., Whaley B., Hipkin R.W., Lin D., Schonbrunn A., et al. beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 272 (1997) 23871-23879
25. Kovoor A., Celver J.P., Wu A., and Chavkin C. Agonist induced homologous desensitization of mu-opioid receptors mediated by G-protein-coupled receptor kinases is dependent on agonist efficacy. Mol Pharmacol 54 (1998) 704-711
26. Oppermann M., Mack M., Proudfoot A.E., and Olbrich H. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 274 (1999) 8875-8885
27. Vigna S.R. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor. Neuropeptides 35 (2001) 24-31
28. Thielemans L., Depoortere I., Van Assche G., Bender E., and Peeters T.L. Demonstration of a functional motilin receptor in TE671 cells from human cerebellum. Brain Res 895 (2001) 119-128
29. Lewis M.M., Watts V.J., Lawler C.P., Nichols D.E., and Mailman R.B. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency. J Pharmacol Exp Ther 286 (1998) 345-353
30. Alvarez V.A., Arttamangkul S., Dang V., Salem A., Whistler J.L., Von Zastrow M., et al. mu-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22 (2002) 5769-5776
31. Perrine S.A., Bennett V.J., and Simmons M.A. Tachykinin peptide-induced activation and desensitization of neurokinin 1 receptors. Peptides 24 (2003) 469-475
32. Stout B.D., Clarke W.P., and Berg K.A. Rapid desensitization of the serotonin (2C) receptor system: effector pathway and agonist dependence. J Pharmacol Exp Ther 302 (2002) 957-962
33. Yu Y., Zhang L., Yin X., Sun H., Uhl G.R., and Wang J.B. Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272 (1997) 28869-28874
34. Chasse S.A., and Dohlman H.G. RGS proteins: G protein-coupled receptors meet their match. Assay Drug Dev Technol 1 (2003) 357-364
35. Siderovski D.P., and Willard F.S. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci 1 (2005) 51-66
36. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signalling. Pharmacol Rev 53 (2001) 1-24
37. Szekeres P.G., Koenig J.A., and Edwardson J.M. The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line. Mol Pharmacol 53 (1998) 759-765
38. Schlag B.D., Lou Z., Fennell M., and Dunlop J. Ligand dependency of 5-hydroxytryptamine 2C receptor internalisation. J Pharmacol Exp Ther 310 (2004) 865-870
39. Nussenzveig D.R., Heinflink M., and Gershengorn M.C. Agonist-stimulated internalization of the thyrotropin-releasing hormone receptor is dependent on two domains in the receptor carboxyl terminus. J Biol Chem 268 (1993) 2389-2392
40. Dhanwada K.R., Vijapurkar U., and Ascoli M. Two mutations of the lutropin/choriogonadotropin receptor that impair signal transduction also interfere with receptor-mediated endocytosis. Mol Endocrinol 10 (1996) 544-554
41. Barak L.S., and Caron M.G. Modeling of sequestration and down regulation in cells containing beta2-adrenergic receptors. J Recept Signal Transduct Res 15 (1995) 677-690
42. Min K.S., Liu X., Fabritz J., Jaquette J., Abell A.N., and Ascoli M. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the Lutropin/Choriogonadotropin receptor. J Biol Chem 273 (1998) 34911-34919
43. Min L., and Ascoli M. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor. Mol Endocrinol 14 (2000) 1797-1810
44. Roettger B.F., Ghanekar D., Rao R., Toledo C., Yingling J., Pinon D., et al. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol 51 (1997) 357-362
45. Holloway A.C., Qian H., Pipolo L., Ziogas J., Miura S., Karnik S., et al. Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol Pharmacol 61 (2002) 768-777
46. Gether U., Lin S., Ghanouni P., Ballesteros J.A., Weinstein H., and Kobilka B.K. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J 16 (1997) 6737-6747
47. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21 (2000) 90-113
48. Kenakin T. Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 42 (2002) 349-379